Narcotics Analgesics Industry - Regional Synopsis
North American Market Forecast
By the end of 2037, North American region is anticipated to hold lucrative narcotics analgesics market share, attributed majorly to the increased consumption of opioids for both medical and non-medical purposes. Over 80% of the world's opioids are consumed in the United States, which has 4.4% of the world's population. About 99% of the hydrocodone used worldwide is used in the US. Moreover, between 2015-2018 about 10.7% of U.S adults aged 20 and above used one or more prescription pain medications (opioid or nonopioid) and 5.7% used one or more prescription opioids, as per the statistics by the Centers for Disease Control and Prevention (CDC). Furthermore, rising cases of arthritis and osteoarthritis in the region are also expected to augment the market growth. In 2020, every 1 in 4 adults in the United States are suffering from arthritis, further, it is estimated around 27 million adults in the region are likely to have arthritis by 2040. In addition to this, the most prevalent joint condition in the US is osteoarthritis. More than 33 million American people will have osteoarthritis by 2020.
